Autoimmune hepatitis

BT Beretta-Piccoli, G Mieli-Vergani… - The Rose and Mackay …, 2024 - Elsevier
Autoimmune hepatitis (AIH) is an inflammatory liver disease, affecting mainly females,
characterized by elevated transaminase and immunoglobulin G (IgG) levels, interface …

Serum biomarkers for autoimmune hepatitis type 1: the case for CD48 and a review of the literature

M Hu, Z You, Y Li, B Huang, N Cui, R Wang… - Clinical Reviews in …, 2022 - Springer
In autoimmune hepatitis (AIH), the persisting inflammation contributes to fibrosis
progression, for which conventional biochemical markers manifest relatively unsatisfactory …

自身免疫性肝炎诊断和治疗指南(2021).

马雄 - … of Clinical Hepatology/Linchuang Gandanbing Zazhi, 2022 - search.ebscohost.com
自身免疫性肝炎(autoimmune hepatitis, AIH) 患者的临床特点包括血清氨基转移酶水平升高,
高免疫球蛋白G 血症, 血清自身抗体阳性, 肝组织学上存在中重度界面性肝炎等 …

Rapid response predicts complete biochemical response and histological remission in autoimmune hepatitis

Y Li, X Xiao, Q Miao, X Ma - Journal of Hepatology, 2022 - journal-of-hepatology.eu
We read with great interest the manuscript by Pape et al. entitled “Systematic review of
response criteria and endpoints in autoimmune hepatitis by the International Autoimmune …

Rare liver diseases are not rare in China

T Lv, J Jia - Liver International, 2022 - Wiley Online Library
Rare diseases, also known as orphan diseases, are a group of diseases that affect a
relatively small number of people. Low incidence rates, atypical symptoms, imperfect …

[HTML][HTML] Advances in clinical detection methods and nanomaterials for autoimmune liver diseases

J Chen, Y Zhu, Q Wang, J Ding, X Chen - Nano TransMed, 2023 - Elsevier
Autoimmune liver disease (AILD) is a kind of chronic liver disease, due to the autoimmune
tolerance of the liver break-down, as well as the imbalance of immune cell numbers and …

Worse fibro-inflammatory activity on diagnostic liver biopsy adversely impacts biochemical remission in autoimmune hepatitis

P Khonde, S Choudhury, NC Spies, N Naz… - Clinics and research in …, 2024 - Elsevier
Background Autoimmune hepatitis (AIH) patients can present with advanced fibrosis at
diagnosis or may progress to the same if biochemical remission on treatment is not …

自身免疫性肝炎患者血清白细胞分化抗原38 和白细胞介素21 水平变化及其临床意义探讨

居峰, 姚上志, 王栋, 叶必星, 蒋丽琳… - 实用肝脏病 …, 2022 - manu43.magtech.com.cn
目的探讨应用血清白细胞分化抗原38 (CD38) 和白细胞介素21 (IL-21) 水平判断自身免疫性肝炎
(AIH) 患者肝组织炎症活动度的效能. 方法2018 年10 月~ 2021 年10 月我院收治的53 例AIH …

Информативность лабораторных маркеров в оценке стадии фиброза печени у детей с аутоиммунным гепатитом первого типа

ОВ Курбатова, ГБ Мовсисян, СВ Петричук… - … и иммунология в …, 2023 - adair.elpub.ru
For citation: Kurbatova OV, Movsisyan GB, Petrichuk SV, Parakhina DV, Demyanov DS,
Kuptsova DG, Radygina TV, Semikina EL, Potapov AS, Freidlin EV. Informative value of …

A nomogram for analyzing risk factors of poor treatment response in patients with autoimmune hepatitis

X Wang, H Liu, P Wang, Y Wang, Y Yi… - European Journal of …, 2024 - journals.lww.com
Objective The objective of this study was to identify biochemical and clinical predictors of
poor response (including incomplete response and non-response) to standard treatment in …